Importance Merkel cell carcinoma (MCC) is a rare and highly aggressive cutaneous
neuroendocrine carcinoma with increasing incidence. Cytotoxic chemotherapy and checkpoint …

… While the diagnosis of Merkel cell carcinoma (MCC) is rare, the incidence has almost
doubled in the United States since 2000. Moreover, when MCC has spread beyond the primary …

… the TMB-H observed in Merkel cell carcinoma of unknown primary tumor (MCC-UP)
patients … , as compared with tumors with Merkel cell carcinoma of known primary tumor (MCC-KP) …

… Associations between biomarkers and response to immune checkpoint inhibitors in metastatic
Merkel cell carcinoma (mMCC) are not fully understood. We report exploratory biomarker …

… burden which has potential prognostic and surveillance value as a tumor biomarker. Merkel
cell carcinoma (MCC) is a rare neuroendocrine skin cancer that requires close monitoring …

… Merkel cell carcinoma (MCC) is an aggressive neuroendocrine … : Merkel cell polyomavirus
(MCPyV)-positive tumors expressing oncogenic viral T antigens, and MCPyV-negative tumors …

… to compare treatment response by clinical and disease-specific biomarkers, including baseline
… A recent study that characterized the genomic landscape of 317 MCC tumors confirmed a …

… lines are frequently used as preclinical models to investigate biological function, we
considered it necessary to establish the genomic landscape of MCC cell lines by whole-exome …

… The genomic landscape of MCC cell lines, which are used as preclinical models in functional
and pharmacological studies, has been analyzed by whole-exome sequencing. In keeping …

… molecular biomarkers such as tumor PD-L1 expression or MCPyV status.2 5 6 Thus, with the
present study we aimed at testing clinically well applicable predictive biomarkers in a larger …